User profiles forAlessandra Bortoluzzi.
 |
Alessandra Bortoluzzi.
University of Ferrara
Verified email at unife.it
Cited by 2188 |
Guidelines for biomarkers in autoimmune rheumatic diseases-evidence based analysis
…, O Berardicurti,M Bombardieri,ABortoluzzi… - Autoimmunity …, 2019 - Elsevier
Autoimmune rheumatic diseases are characterised by an abnormal immune system response,
complement activation, cytokines dysregulation and inflammation. In last years, despite …
complement activation, cytokines dysregulation and inflammation. In last years, despite …
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus
ABortoluzzi,CA Scirè年代Bombardieri,L Caniatti… - …, 2015 - academic.oup.com
Objective. The aim of this study was to develop and validate an algorithm to assist the attribution
of neuropsychiatric (NP) events to underlying disease in SLE patients. Methods. Phase …
of neuropsychiatric (NP) events to underlying disease in SLE patients. Methods. Phase …
Osteoarthritis and its management-Epidemiology, nutritional aspects and environmental factors
ABortoluzzi, F Furini,CA Scirè- Autoimmunity reviews, 2018 - Elsevier
Osteoarthritis (OA) is the most prevalent chronic rheumatic diseases worldwide, with a
strong impact on individual and population health. OA is a clinically heterogeneous disease …
strong impact on individual and population health. OA is a clinically heterogeneous disease …
[PDF][PDF]One year in review 2019: systemic lupus erythematosus
…, E Calabresi, V Signorini,ABortoluzzi... - Clin Exp ......，2019 - Clinexprheumatol.org
Systemic lupus erythematosus (SLE) is an autoimmune connective-tissue disorder with a
wide range of clinical manifestations that predominantly affect women. Many aspects of its …
wide range of clinical manifestations that predominantly affect women. Many aspects of its …
Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus
I Gergianaki,ABortoluzzi, G Bertsias - Best Practice & Research Clinical …, 2018 - Elsevier
Obtaining an updated view of the epidemiology, risk factors, and prognosis of systemic
lupus erythematosus (SLE) is pivotal to our understanding of the disease burden. Recent …
lupus erythematosus (SLE) is pivotal to our understanding of the disease burden. Recent …
Systemic lupus erythematosus: state of the art on clinical practice guidelines
…, T Alexander,Z Amoura, T Avcin,ABortoluzzi… - RMD open, 2019 - rmdopen.bmj.com
Systemic lupus erythematosus (SLE) is the paradigm of systemic autoimmune diseases
characterised by a wide spectrum of clinical manifestations with an unpredictable relapsing-…
characterised by a wide spectrum of clinical manifestations with an unpredictable relapsing-…
Early disease and low baseline damage as predictors of response to belimumab in patients with systemic lupus erythematosus in a Real‐Life setting
…, F Ceccarelli, F Conti,ABortoluzzi… - Arthritis & …, 2020 - Wiley Online Library
Objective To investigate predictors of response, remission, low disease activity, damage,
and drug discontinuation in patients with systemic lupus erythematosus ( SLE ) who were …
and drug discontinuation in patients with systemic lupus erythematosus ( SLE ) who were …
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric …
Objective To investigate efficacy, safety and survival of belimumab and to identify predictors
of drug response and drug discontinuation in patients with active SLE in clinical practice. …
of drug response and drug discontinuation in patients with active SLE in clinical practice. …
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal …
Objectives Classification criteria are biased towards classifying long-standing disease. We
compared the European League Against Rheumatism (EULAR)/American College of …
compared the European League Against Rheumatism (EULAR)/American College of …
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective …
M Govoni年代Bombardieri,ABortoluzzi, L Caniatti… - …, 2012 - academic.oup.com
Objective. To analyse risk factors and comorbidities potentially associated with CNS involvement
in a large cohort of Italian patients affected by SLE. Methods. A number of generic (not …
in a large cohort of Italian patients affected by SLE. Methods. A number of generic (not …